Literature DB >> 20795964

Prognosis and surgical treatment of gastric cancer invading adjacent organs.

Ming Zhang1, Hongfeng Zhang, Yan Ma, Guanyu Zhu, Yingwei Xue.   

Abstract

BACKGROUND: The prognostic factors and surgical management of gastric cancer invading adjacent organs remains controversial. The aim was to provide valuable prognostic and surgical information on patients with gastric cancer invading adjacent organs.
METHODS: The retrospectively study included 367 patients who underwent gastric resection for gastric cancer invading adjacent organs. Clinicopathologic variables were evaluated as predictors of long-term survival by univariate and multivariate analyses. Multivariate analysis was performed using Cox's proportional hazards model.
RESULTS: The five-year survival rate was 10.1%, and median survival period was 14 months. The five-year survival rate was influenced by histologic type, lymph node metastasis, liver metastasis, peritoneal dissemination, extent of lymph node dissection and curability of operation. Of these, independent prognostic factors were lymph node metastasis (N2, N3 versus N0, N1, relative risk 2.028, P < 0.001), liver metastasis (present versus absent, relative risk 1.582, P= 0.023) and curative resection (no versus yes, relative risk 1.719, P < 0.001). A significant survival benefit for curative resection was observed with a five-year survival rate of 21.5% compared with non-curatively resected cases (5.1%).
CONCLUSIONS: In patients with gastric cancer invading adjacent organs, three independent prognostic factors were lymph node metastasis, liver metastasis, and curative resection. For patients with gastric cancer invading adjacent organs, we recommend performing combined organ resection in patients with locally advanced gastric carcinoma regardless of curability.

Entities:  

Mesh:

Year:  2010        PMID: 20795964     DOI: 10.1111/j.1445-2197.2010.05376.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

Review 1.  Systematic review of pancreaticoduodenectomy for locally advanced gastric cancer.

Authors:  Patrick Roberts; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-08-26       Impact factor: 7.370

Review 2.  Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival.

Authors:  Hamid Reza Raziee; Roberta Cardoso; Rajini Seevaratnam; Alyson Mahar; Lucy Helyer; Calvin Law; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-12-03       Impact factor: 7.370

3.  Multivisceral Resection for Locally Advanced Gastric and Gastroesophageal Junction Cancers-11-Year Experience at a High-Volume North American Center.

Authors:  J C Molina; A Al-Hinai; A Gosseling-Tardif; P Bouchard; J Spicer; D Mulder; C L Mueller; L E Ferri
Journal:  J Gastrointest Surg       Date:  2018-04-16       Impact factor: 3.452

4.  Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.

Authors:  Yi-Chen Wu; Ping Lv; Jing Han; Jiang-Liu Yu; Xin Zhu; Lian-Lian Hong; Wang-Yu Zhu; Qi-Ming Yu; Xin-Bao Wang; Pei Li; Zhi-Qiang Ling
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

5.  Over-expression of Metastasis-associated in Colon Cancer-1 (MACC1) Associates with Better Prognosis of Gastric Cancer Patients.

Authors:  Shao-Hua Ge; Xiao-Jiang Wu; Xiao-Hong Wang; Xiao-Fang Xing; Lian-Hai Zhang; Yu-Bing Zhu; Hong Du; Bin Dong; Ying Hu; Jia-Fu Ji
Journal:  Chin J Cancer Res       Date:  2011-06       Impact factor: 5.087

6.  Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.

Authors:  Jing Guo; Bin Dong; Jia-Fu Ji; Ai-Wen Wu
Journal:  World J Gastroenterol       Date:  2012-10-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.